Key Takeaways
- Punjab government orders recall of two medicine batches.
- Batch 176 of Injection Mecodax and Batch BCT-005 of Cetirizine Dihydrochloride are affected.
- Consumers advised to stop using the medicines immediately.
The Punjab government has ordered a recall of two specific medicine batches due to quality failures, according to a directive from the Provincial Quality Control Board.
The recalled batches include Batch 176 of Injection Mecodax, with an expiry date of August 2027, and Batch BCT-005 of film-coated Cetirizine Dihydrochloride 10mg, with an expiry date of February 2027.
The Directorate of Drug Control, Punjab, issued the alert under No. 132/2026, directing manufacturers, market authorization holders, and distributors to immediately recall the affected products and complete the distribution-recall process.
Pharmacies, medical stores, wholesalers, distributors, and healthcare facilities have been instructed to stop dispensing the batches and report stock and consumption records to the relevant drug inspectors.
Consumers and patients have been advised to stop using the affected medicines at once due to potential health risks.
Manufacturers are required to conduct a root-cause analysis and submit a Corrective and Preventive Action plan to the drug control department.
Anyone experiencing adverse reactions after using the affected medicines is encouraged to report them through the Medicine Surveillance System.
The recall is part of ongoing efforts to ensure the safety and quality of pharmaceutical products in the province.
